Search

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31–June 4, in Chicago.

… Thursday, May 23, 2024 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

… Wednesday, February 20, 2013 Summary Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research. Charles L. Sawyers , Chair of Memorial Sloan Kettering’s Human Oncology

Jeffrey Zwicker, MD, has been named Chief of the Hematology Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from Harvard University Medical School, where he was an Associate Professor of Medicine, and Beth Israel Deaconess Medical Center (BIDMC), where he served as Chief of Benign Hematology in the Division of Hematology since 2017. Dr. Zwicker succeeds MSK’s Interim Hematology Service Chief, Marcel van den Brink, MD, PhD.

… Wednesday, November 30, 2022 Jeffrey Zwicker, MD ,   has been named Chief of the Hematology Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from Harvard University Medical School, where he was an Associate Professor of Medicine, and   Beth Israel Deaconess Medical Center (BIDMC)

In honor of Women's History Month, meet the scientific hero who helped raise money and awareness for AIDS research.

… Wednesday, March 13, 2019 Summary In honor of Women’s History Month, we’re remembering female scientists from MSK’s past who shook up cancer research. Read about Charlotte Friend and Ora Rosen . In 1981, Mathilde Krim, an immunologist at the Sloan Kettering Institute , was exploring the role of naturally

In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role in these successes, as they work together with the common goal of using their discoveries to create new treatments for people with cancer.

… Friday, August 12, 2022 In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role

The list honors health care leaders who envision a better future for all New Yorkers.

… Wednesday, December 1, 2021 Craig B. Thompson, MD , President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to the first AMNY Metro and PoliticsNY ’s Power Players in Health Care list. The list salutes top public officials, policymakers, hospital and health maintenance organization

Sometimes a BRCA mutation is just along for the ride, rather than driving a tumor’s development.

… Wednesday, July 10, 2019 VIDEO | 00:54 Watch: Not All BRCA Mutations Cause Patients' Cancer, Study Finds Computational biologist Barry Taylor discusses findings of a new study about BRCA genes. Video Details Summary Scientists at Memorial Sloan Kettering have discovered that BRCA1 and BRCA2 mutations

A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story.

… Wednesday, September 11, 2024 A team of doctors and researchers at Memorial Sloan Kettering Cancer Center (MSK) have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Their findings, which include a detailed analysis of the clinical and

Un equipo de médicos e investigadores de MSK ha identificado un nuevo y raro tipo de cáncer pulmonar de células pequeñas que afecta principalmente a personas jóvenes que nunca han fumado. Descubra cómo un paciente de 19 años inspiró una historia de investigación.

… Wednesday, September 11, 2024 Un equipo de médicos e investigadores del Memorial Sloan Kettering Cancer Center (MSK) ha identificado un nuevo y raro tipo de cáncer pulmonar de células pequeñas que afecta principalmente a personas jóvenes que nunca han fumado. Sus hallazgos, que incluyen un análisis detallado

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

… Wednesday, September 25, 2013 Summary A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis. A new imaging approach being investigated by Memorial Sloan Kettering researchers